These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27168335)

  • 1. Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.
    Wilson SE; Rosella LC; Wang J; Le Saux N; Crowcroft NS; Harris T; Bolotin S; Deeks SL
    PLoS One; 2016; 11(5):e0154340. PubMed ID: 27168335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.
    Wilson SE; Rosella LC; Wang J; Renaud A; Le Saux N; Crowcroft NS; Desai S; Harris T; Bolotin S; Gubbay J; Deeks SL
    Vaccine; 2019 Apr; 37(17):2408-2414. PubMed ID: 30765171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.
    Hartwig S; Uhari M; Renko M; Bertet P; Hemming M; Vesikari T
    BMC Health Serv Res; 2014 Dec; 14():632. PubMed ID: 25494641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in Emergency Department Visits for Acute Gastroenteritis Among Children in 10 US States After Implementation of Rotavirus Vaccination, 2003 to 2013.
    Shah MP; Tate JE; Steiner CA; Parashar UD
    Pediatr Infect Dis J; 2016 Jul; 35(7):782-6. PubMed ID: 27088585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a publicly funded monovalent rotavirus vaccination program in the Province of Quebec (Canada).
    Comeau JL; Gagneur A; Quach C
    Vaccine; 2016 Feb; 34(7):893-8. PubMed ID: 26795368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.
    Kõivumägi K; Toompere K; Soeorg H; Kallas E; Jõgeda EL; Huik K; ; Lutsar I
    Vaccine; 2020 Mar; 38(13):2879-2886. PubMed ID: 32067818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections.
    Zlamy M; Kofler S; Orth D; Würzner R; Heinz-Erian P; Streng A; Prelog M
    BMC Infect Dis; 2013 Mar; 13():112. PubMed ID: 23452879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
    Bégué RE; Perrin K
    Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Rotavirus Vaccines on Gastroenteritis Hospitalizations in Western Australia: A Time-series Analysis.
    Fathima P; Jones MA; Moore HC; Blyth CC; Gibbs RA; Snelling TL
    J Epidemiol; 2021 Aug; 31(8):480-486. PubMed ID: 32801278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.
    Enane LA; Gastañaduy PA; Goldfarb DM; Pernica JM; Mokomane M; Moorad B; Masole L; Tate JE; Parashar UD; Steenhoff AP
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S168-74. PubMed ID: 27059352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.
    Hemming-Harlo M; Vesikari T; Uhari M; Renko M; Salminen M; Torcel-Pagnon L; Hartwig S; Simondon F; Bricout H
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):317-323. PubMed ID: 27760800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
    Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
    Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs.
    Donauer S; Payne DC; Edwards KM; Szilagyi PG; Hornung RW; Weinberg GA; Chappell J; Hall CB; Parashar UD; Staat MA
    Vaccine; 2013 May; 31(24):2692-7. PubMed ID: 23583814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccine.
    Tate JE; Curns AT; Cortese MM; Weintraub ES; Hambidge S; Zangwill KM; Patel MM; Baggs JM; Parashar UD
    Pediatrics; 2009 Mar; 123(3):744-9. PubMed ID: 19254997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001-2016.
    Baker JM; Dahl RM; Cubilo J; Parashar UD; Lopman BA
    BMC Infect Dis; 2019 Feb; 19(1):186. PubMed ID: 30795739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
    Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
    Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.
    Thomas SL; Walker JL; Fenty J; Atkins KE; Elliot AJ; Hughes HE; Stowe J; Ladhani S; Andrews NJ
    Vaccine; 2017 Jan; 35(4):680-686. PubMed ID: 28007397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.